TENOFOSHIV-EM

TENOFOSHIV-EM

TENOFOSHIV-EM is a high-quality combination allopathic antiviral medicine offered by Sigma Nexus, a trusted pharmaceutical exporter and supplier based in Jaipur, India. With over 10 years of industry experience, Sigma Nexus is dedicated to delivering safe, effective, and globally compliant pharmaceutical products to both domestic and international markets. Manufactured in WHO-GMP and ISO-certified facilities, TENOFOSHIV-EM meets stringent international quality standards, ensuring consistent performance, safety, and reliability.

TENOFOSHIV-EM is primarily used in the treatment and management of Human Immunodeficiency Virus (HIV) infection. It is a combination antiviral formulation that typically includes Tenofovir and Emtricitabine, both of which belong to the class of nucleotide/nucleoside reverse transcriptase inhibitors (NRTIs). These active ingredients work together to block the action of reverse transcriptase, an enzyme essential for viral replication. By inhibiting this process, TENOFOSHIV-EM helps reduce the viral load in the body, slows down disease progression, and strengthens the immune system.

This combination therapy is widely used as part of antiretroviral treatment (ART) regimens and may also be prescribed in certain cases for pre-exposure prophylaxis (PrEP) under medical supervision. Its dual-action formulation enhances treatment effectiveness and helps in achieving long-term viral suppression when used consistently as prescribed. TENOFOSHIV-EM plays a crucial role in improving the quality of life for individuals living with HIV by reducing the risk of complications and transmission.

Formulated using high-purity active pharmaceutical ingredients (APIs), TENOFOSHIV-EM ensures optimal bioavailability and reliable therapeutic outcomes. Sigma Nexus follows strict quality control and assurance protocols at every stage of manufacturing, including raw material sourcing, formulation, packaging, and final inspection. Each batch undergoes rigorous testing to comply with global pharmaceutical standards, ensuring safety and efficacy for patients worldwide.

Sigma Nexus has established a strong presence in international markets, exporting pharmaceutical products to regions such as the USA, UK, UAE, Africa, and Southeast Asia. With an efficient logistics and supply chain network, the company ensures timely delivery and uninterrupted availability of essential medicines like TENOFOSHIV-EM. The product is securely packaged to maintain its stability, potency, and shelf life during transportation and storage.

In addition to supplying finished formulations, Sigma Nexus offers value-added services such as third-party manufacturing and private labeling. These services enable global partners to customize packaging, branding, and product specifications according to their specific market requirements. The company also provides complete support for product registration and regulatory compliance, helping clients navigate approval processes across various countries.

TENOFOSHIV-EM should be used strictly under the supervision of a qualified healthcare professional. The dosage and duration of treatment depend on the patient’s health condition and response to therapy. Regular monitoring is essential to ensure treatment effectiveness and safety.

With a strong commitment to quality, innovation, and customer satisfaction, Sigma Nexus continues to grow as a reliable pharmaceutical exporter from India. By offering advanced combination antiviral solutions like TENOFOSHIV-EM, the company contributes significantly to improving global access to life-saving HIV treatments and enhancing overall healthcare outcomes.